(Q42981120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Hepatitis C virus NS3/4A protease blocks IL-28 production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Bing Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jie Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Yong-Jun Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jin Zhong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

2374-2382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22685015%20AND%20SRC:MED&resulttype=core&format=json

IL-28, IL-29 and their class II cytokine receptor IL-28R

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Triggering the interferon antiviral response through an IKK-related pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

VISA is an adapter protein required for virus-triggered IFN-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

The N-terminal helix α(0) of hepatitis C virus NS3 protein dictates the subcellular localization and stability of NS3/NS4A complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IFN-lambda determines the intestinal epithelial antiviral host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Replication of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242388

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/EJI.201242388

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dpiorl24ejbfflrnwwoe7eso6e

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_dpiorl24ejbfflrnwwoe7eso6e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dpiorl24ejbfflrnwwoe7eso6e

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/dpiorl24ejbfflrnwwoe7eso6e

1 reference

30 July 2022